News

All News Blog Events

SK pharmteco to Expand Capabilities with Acquisition of Controlling Interest in Center for Breakthrough Medicines

20 September 2023

Yposkesi inaugurates €60M biomanufacturing site for cell and gene therapies

‘Choose France’ Yposkesi welcomes French Ministers to newly constructed 5,000m2 site – under government scheme

Yposkesi launches LentiSure™, Lentiviral (LV) Vector production platform optimized for higher yields

Yposkesi reinforces team with three executive appointments

Logos Asma Consortium

ASMA Consortium: Improving access to innovative bio therapeutics through acoustic technologies

22 February 2022

New Yposkesi factory

Yposkesi launches construction of its second bioproduction site.

Yposkesi front office

Yposkesi welcomes SK Group as new majority equity shareholder, forging solid industrial partnership for growth.

Yposkesi front office

Apres le Génopole, Novartis choisit l’Essonne pour ses therapies géniques

9 December 2020

Brian Mullan

Yposkesi welcomes Brian Mullan, PhD, as director of innovation, analytical and process development

8 December 2020

Load more News

Would you like to know more ?